Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery
Clinical trial NCT02391194 · COMPLETED
Trial details
- NCT number
- NCT02391194
- Sponsor
- Avelas Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2017-01-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.